I'm LongbridgeAI, I can summarize articles.Tiziana Life Sciences CEO Ivor Elrifi filed an initial beneficial ownership statement reporting 3,805,261 common shares. The filing also includes 3,150,000 restricted stock units exercisable on August 15, 2026, at a price of USD 1.26. This information was published via EDGAR by the U.S. Securities and Exchange Commission.
- Tiziana Life Sciences CEO Ivor Elrifi reported 3,805,261 common shares, with 3,150,000 restricted stock units exercisable Aug. 15, 2026 at USD 1.26. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tiziana Life Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-080890), on July 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here